Anuh Pharma Limited (ANUHPHR) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE489G01022
Key metrics
- Market Cap
- ₹762 Cr
- P/E Ratio
- 21.24
- EPS
- 3.58
- Book Value
- 35.14
- P/B Ratio
- 2.17
- ROE
- 11.65%
- ROCE
- 16.16%
- Debt / Equity
- 0
- Net Margin
- 5.32%
- Revenue Growth
- 16.65%
- Profit Growth
- -13.32%
- Dividend Yield
- 1.97%
- 52W High
- ₹93.00
- 52W Low
- ₹67.00
- Market Cap Band
- small cap
- Face Value
- 5
Ratios computed from the annual results period ending 2026-03-31.
About Anuh Pharma Limited
Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 323
- Promoter Holding
- 72.89%
The full Anuh Pharma Limited analysis
Create a free account to open the complete ANUHPHR deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.